News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
TS Picks: CRISPR Patent Edition
Kerry Grens | Jan 5, 2016
A challenge to the first CRISPR patent just got teeth.
Opinion: Translation Nation
Kathleen Marsman and Lisa McKerracher | Nov 18, 2015
What’s in store for commercialization grants at the Canadian Institutes of Health Research?
Who Owns CRISPR?
Jenny Rood | Apr 3, 2015
With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.
Ocean Acidification Harming Shellfish
Bob Grant | Dec 17, 2014
Researchers determine why larval oysters and mussels are sensitive to reduced pH.
Competition for CRISPR Commercialization
Kerry Grens | May 1, 2014
Researchers stake their proprietary claim on the genome-editing technique.
Opinion: Pressured to Commercialize
Timothy Caulfield | May 28, 2012
Is the push for science to save the still flailing economy a threat to scientific research?
Universities Spawn More Startups
Tia Ghose | Nov 2, 2011
Despite the down economy, universities are ramping up their efforts to commercialize their research.